Physician

Atul Dattatraya Rajpurkar, M.D.

According to 2025 Medicare claims, Atul Rajpurkar, M.D. (NPI: 1497951289) practices urology in the Saginaw, MI market, with the plurality of this provider's patient population coming from Saginaw, MI. This provider's primary affiliated billing organization is COVENANT MEDICAL CENTER, INC (NPI: 1619412376; TIN: 383369438) and primary practice location at 48603-2423. Rajpurkar is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Rajpurkar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 394 traditional Medicare patients, billed 2,288 HCPCS/CPT codes, and received $151,909 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 2,138 prescription claims across 830 beneficiaries totaling $906,792 in drug costs, led by Xtandi (Enzalutamide). DME data shows 12 claims. Open Payments data shows 14 records totaling $300. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $25,201 to $906,792. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $165 to $222.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	535	1,987	$176,841
2016	466	2,560	$168,321
2017	567	2,319	$185,516
2018	569	3,664	$193,543
2019	586	3,285	$164,667
2020	324	1,004	$68,786
2021	284	2,199	$100,830
2022	326	1,763	$133,821
2023	459	2,209	$173,093
2024	394	2,288	$151,909

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	230	702	$25,201
2016	265	809	$39,508
2017	301	915	$38,594
2018	303	873	$44,278
2019	298	764	$45,701
2020	260	642	$123,396
2021	413	963	$73,716
2022	484	1,158	$158,956
2023	763	1,890	$431,177
2024	830	2,138	$906,792

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	37	$3,988
2019	N/R	67	$6,783
2020	N/R	49	$5,911
2021	N/R	19	$3,857
2022	N/R	N/R	N/R
2023	N/R	39	$11,853
2024	N/R	12	$2,990

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	126	134	$164
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	83	83	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	174	248	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	94	104	$63
51798	Ultrasound measurement of bladder capacity after voiding	66	71	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	53	1,590	$762,549
Myrbetriq	Mirabegron	43	3,085	$43,767
Gemtesa	Vibegron	42	2,406	$36,946
Tamsulosin Hcl	Tamsulosin Hcl	621	51,101	$13,661
Mirabegron Er	Mirabegron	18	1,140	$11,990

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	12	$2,990

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$300	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Atul Dattatraya Rajpurkar, M.D.?

Tedicare shows public-source Medicare data for Atul Dattatraya Rajpurkar, M.D. (NPI 1497951289), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Atul Dattatraya Rajpurkar, M.D. have ACO affiliation data?

Atul Dattatraya Rajpurkar, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Atul Dattatraya Rajpurkar, M.D.?

Atul Dattatraya Rajpurkar, M.D. is linked to COVENANT MEDICAL CENTER, INC (billing NPI 1619412376) in the available physician profile data.

Does Atul Dattatraya Rajpurkar, M.D. have Open Payments data?

Atul Dattatraya Rajpurkar, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.